{"abdominal distension": 2.39, "amyloidosis": 153.94, "ascites": 2.41, "atrial fibrillation": 8.28, "atrial flutter": 15.31, "atrioventricular block complete": 7.11, "balance disorder": 2.24, "brain natriuretic peptide increased": 28.93, "cardiac amyloidosis": 781.28, "cardiac disorder": 4.58, "cardiac failure": 26.8, "cardiac failure chronic": 298.24, "cardiac failure congestive": 3.62, "cardiomyopathy": 10.96, "carpal tunnel syndrome": 11.68, "cerebral infarction": 2.39, "cerebrovascular accident": 2.04, "condition aggravated": 4.69, "death": 2.58, "dementia": 4.99, "diastolic dysfunction": 39.28, "disease progression": 10.5, "disease recurrence": 2.74, "dysphagia": 4.08, "dyspnoea exertional": 5.75, "ejection fraction decreased": 9.75, "fall": 3.11, "flatulence": 3.56, "fluid retention": 5.44, "gait inability": 2.38, "gamma-glutamyltransferase increased": 2.62, "gastrointestinal disorder": 2.05, "general physical health deterioration": 3.05, "glomerular filtration rate decreased": 7.01, "gout": 6.79, "hereditary neuropathic amyloidosis": 5866.85, "hypervolaemia": 8.15, "hypoacusis": 2.24, "left ventricular dysfunction": 12.5, "left ventricular hypertrophy": 64.47, "loss of personal independence in daily activities": 2.97, "mitral valve incompetence": 13.77, "n-terminal prohormone brain natriuretic peptide increased": 67.2, "neuropathy peripheral": 2.64, "oedema": 2.59, "oedema peripheral": 3.01, "off label use": 3.55, "orthostatic hypotension": 4.61, "pericardial effusion": 3.7, "pleural effusion": 3.78, "polyneuropathy": 11.08, "product use in unapproved indication": 4.87, "pulmonary oedema": 2.13, "therapeutic response unexpected": 5.6, "tricuspid valve incompetence": 19.9, "urinary tract infection": 2.14, "ventricular hypokinesia": 25.48, "weight decreased": 3.52}